Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Tomoki Ryu"'
Publikováno v:
Asian Journal of Surgery, Vol 45, Iss 1, Pp 202-207 (2022)
Background: The prognostic nutritional index (PNI) is used to assess immune and nutritional status, and is a prognostic factor for several malignant tumors. However, little evidence exists regarding the predictive impact of prognostic nutritional ind
Externí odkaz:
https://doaj.org/article/ab1cb77144f444e3a51d680efedb8fe3
Autor:
Tomoki Ryu, Yuko Takami, Yoshiyuki Wada, Shin Sasaki, Hajime Imamura, Hiroki Ureshino, Hideki Saitsu
Publikováno v:
Asian Journal of Surgery, Vol 44, Iss 1, Pp 186-191 (2021)
Background: It remains to be clarified whether combined hepatectomy and microwave ablation for multifocal hepatocellular carcinoma (HCC) is feasible. This aim of this study was to examine the perioperative and oncological outcomes after combined hepa
Externí odkaz:
https://doaj.org/article/3bd522cb91dd401db68ddb0175b2f2f8
Autor:
Shin Sasaki, Yuko Takami, Yoshiyuki Wada, Tomoki Ryu, Hajime Imamura, Hiroki Ureshino, Minako Fujiwara, Hideki Saitsu
Publikováno v:
Surgical Case Reports, Vol 6, Iss 1, Pp 1-6 (2020)
Abstract Background Glomus tumors (GTs) are mesenchymal neoplastic lesions arising from the glomus bodies and generally occur in the fingers and toes. Gastrointestinal GTs are rare, and most of them originate from the stomach; however, GT arising fro
Externí odkaz:
https://doaj.org/article/847edc4721344e1aa980e4d548bdb8ce
Autor:
Hiroharu Ito, Yoshiyuki Wada, Yuko Takami, Tomoki Ryu, Hiroki Ureshino, Hajime Imamura, Shin Sasaki, Akihisa Ohno, Masayuki Hijioka, Toyoma Kaku, Ken Kawabe, Shigeto Kawauchi, Hideki Saitsu
Publikováno v:
Surgical Case Reports, Vol 6, Iss 1, Pp 1-6 (2020)
Abstract Background Gastroenteric neuroendocrine carcinomas (NECs) account for 6.2% of gastroenteric neuroendocrine tumors (NETs), and only 1% or less of gastroenteric NETs occur in the ampulla of Vater (AoV). Clinical features of NEC of the AoV rema
Externí odkaz:
https://doaj.org/article/20826cab90814c1e8945b3c5fab17bb1
Autor:
Yoshiyuki Wada, Yuko Takami, Tomoki Ryu, Hiroki Ureshino, Hajime Imamura, Shin Sasaki, Hideki Saitsu
Publikováno v:
Case Reports in Oncology, Vol 13, Iss 1, Pp 379-384 (2020)
A 73-year-old male was initially treated with sorafenib for advanced stage HCC. However, the disease progressed 2 months after starting sorafenib. Progressive disease (PD) was confirmed by radiological examination, which revealed mediastinal and abdo
Externí odkaz:
https://doaj.org/article/0fcced4907d2499581d62962eee01fac
Autor:
Yo Sato, Takanobu Hara, Yuko Takami, Yoshiyuki Wada, Tomoki Ryu, Shin Sasaki, Munehiro Yoshitomi, Seiya Momosaki, Masatoshi Murakami, Masayuki Hijioka, Toyoma Kaku, Ken Kawabe, Hideki Saitsu
Publikováno v:
Surgical Case Reports, Vol 5, Iss 1, Pp 1-6 (2019)
Abstract Background Carcinoma of the ampulla of Vater with distant metastases is regarded as unresectable. Systemic chemotherapy is basically the treatment of choice for such tumors. Case presentation A 68-year-old woman was referred to our hospital
Externí odkaz:
https://doaj.org/article/3b118be108084223b46fe0f0e034d9cf
Autor:
Tomoki Ryu, Yuko Takami, Yoshiyuki Wada, Masaki Tateishi, Hajime Matsushima, Munehiro Yoshitomi, Hideki Saitsu
Publikováno v:
Asian Journal of Surgery, Vol 42, Iss 1, Pp 100-105 (2019)
Summary: Background: Indications and efficacy of surgical treatment for liver metastases from gastric cancer (LMGCs) remain controversial. This retrospective study was designed to clarify the benefits of surgical treatment and identify prognostic fac
Externí odkaz:
https://doaj.org/article/321bbe0397244af2a93ecc61bd18807c
Publikováno v:
Asian Journal of Surgery, Vol 43, Iss 9, Pp 953-954 (2020)
Externí odkaz:
https://doaj.org/article/c14d6fc9de5f4c94a2aef5c36b6ff41e
Autor:
Eisuke Katafuchi, Yuko Takami, Yoshiyuki Wada, Masaki Tateishi, Tomoki Ryu, Kazuhiro Mikagi, Hideki Saitsu
Publikováno v:
Case Reports in Gastroenterology, Vol 9, Iss 2, Pp 285-290 (2015)
Sorafenib is an effective treatment for unresectable hepatocellular carcinoma (HCC) characterized by disease stabilization. However, the response rates are very low (
Externí odkaz:
https://doaj.org/article/3af82bd89d424aec9f0fd6cb6677658c
Publikováno v:
PLoS ONE, Vol 11, Iss 1, p e0146456 (2016)
Whether radiologically detected progressive disease (PD) is an accurate metric for discontinuing sorafenib treatment in patients with hepatocellular carcinoma (HCC) is unclear. We investigated the efficacy of sorafenib treatment after radiologic conf
Externí odkaz:
https://doaj.org/article/1260098718824c0e8b9247b42d064590